https://orcid.org/0000-0001-7709-6870
References
- Federation of Clinical Immunology Societies . About FOCIS – FOCIS. www.focisnet.org/about-focis/
- Federation of Clinical Immunology Societies . FCEs – FOCIS. www.focisnet.org/communities/fces/
- Millennium Institute on Immunology and Immunotherapy . IMII – Instituto Milenio en Inmunología e Inmunoterapia. www.imii.cl/en/quienes-somos/
- Kalergis AM , AnegonI , GonzálezPA. FOCIS goes south: advances in translational and clinical immunology. Immunotherapy9(10), 789–792 (2017).
- Abbas AK , LichtmanAH , PillaiS , BakerDL. Cellular and Molecular Immunology (10th Edition).Elsevier, PA, USA (2022).
- Murphy KM , WeaverC. Janeway’s Immunobiology (9th Edition).Garland Science, NY, USA (2017).
- Picarda E , BézieS , BoucaultLet al. Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells. JCI Insight2(3), e90088 (2017).
- Boucault L , LopezRobles M-D , ThiolatAet al. Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease. Blood Adv.4(11), 2501–2515 (2020).
- Besnard M , SérazinC , OssartJet al. Anti-CD45RC antibody immunotherapy for the treatment of the auto-immune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome. J. Clin. Invest.132(7), e156507 (2022).
- Roncarolo MG , GregoriS , BacchettaR , BattagliaM , GaglianiN. The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity49(6), 1004–1019 (2018).
- Kühn R , LöhlerJ , RennickD , RajewskyK , MüllerW. Interleukin-10-deficient mice develop chronic enterocolitis. Cell75(2), 263–274 (1993).
- Groux H , O’GarraA , BiglerMet al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature389(6652), 737–742 (1997).
- Barzaghi F , AmayaHernandez LC , NevenBet al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study. J. Allergy Clin. Immunol.141(3), 1036–1049.e5 (2018)
- Bacchetta R , BarzaghiF , RoncaroloM-G. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann. NY Acad. Sci.1417(1), 5–22 (2018).
- Glocker E-O , KotlarzD , BoztugKet al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med.361(21), 2033–2045 (2009).
- Sato Y , PasseriniL , PieningBDet al. Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses in vivo. Clin. Transl. Immunol.9(11), e1214 (2020)
- Chabalgoity JA , DouganG , MastroeniP , AspinallRJ. Live bacteria as the basis for immunotherapies against cancer. Expert Rev. Vaccines1(4), 495–505 (2002).
- Agorio C , SchreiberF , SheppardMet al. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma. J. Gene Med.9(5), 416–423 (2007).
- Grille S , MorenoM , BascuasTet al. Salmonella enterica serovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect. Immunology143(3), 428–433 (2014).